Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Hope: Antibody-Mucus Interactions |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2014-12-03 |
| Study Made Public: | 2016-09-22 |
Title
Neutralization assay using the MUC5AC at constant concentration of (0.5mg/ml) and serial dilution of HIV-1 antibody panel.
Description
CAVD 472 (MUC5AC) is an immunogenicity study to identify which antibodies respond to the presence of MUC5a/c, an oligomeric gel forming human mucin subtype.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.